Submit Deal

MELINTA THERAPEUTICS

Summary

Melinta Therapeutics is the largest pure-play antibiotics company.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 153 M

Avg. Deal Size£ 77 M

Market Context

Senior Management

Sort

Target: MELINTA THERAPEUTICS

Bidder: DEERFIELD MANAGEMENT COMPANY

9 Service Providers

23 Dealmakers

£ 107 M

Value

Target: TETRAPHASE PHARMACEUTICALS

Bidder: MELINTA THERAPEUTICS

5 Service Providers

3 Dealmakers

£ 45 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy